Form D · Biotechnology
Qualia Oto, Inc.
Dallas, TX · CIK 0001900746
Offering snapshot reported Jan 14, 2022 · SEC filing
- Reported sold
- $1.42M Offering amount: $2M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 31, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2022 | Initial | $1,420,001 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-429616
Source: Form D, filed Jan 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Connie Manz | Director, Executive |
| Walter Voit | Executive |
| Benedict Voit | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17217 Waterview Parkway, Suite 1.202
Dallas, TX, 75252
Dallas, TX, 75252